SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-328277
Filing Date
2014-09-02
Accepted
2014-09-02 10:12:53
Documents
3
Period of Report
2014-09-02

Document Format Files

Seq Description Document Type Size
1 6-K d785005d6k.htm 6-K 11115
2 EX-99.1 d785005dex991.htm EX-99.1 5409
3 GRAPHIC g785005img001.jpg GRAPHIC 7620
  Complete submission text file 0001193125-14-328277.txt   28169
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 141076662
SIC: 2834 Pharmaceutical Preparations